UR
KERX

USCA RIA’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

USCA RIA’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,700
Closed -$36K – 490
2018
Q3 		$36K Sell
10,700
-5,900
-36% -$21.3K ﹤0.01% 467
2018
Q2 		$62K Sell
16,600
-1,500
-8% -$7.3K 0.01% 448
2018
Q1 		$74K Sell
18,100
-1,000
-5% -$4.66K 0.01% 434
2017
Q4 		$89K Sell
19,100
-1,700
-8% -$9.37K 0.01% 425
2017
Q3 		$150K Hold
20,800
– – 0.02% 398
2017
Q2 		$150K Hold
20,800
– – 0.02% 404
2017
Q1 		$128K Buy
+20,800
New +$114K 0.02% 389

USCA RIA's KERX Position: Q4 2018 in Review

USCA RIA sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 10,700 shares — an estimated $36K sold.

USCA RIA first reported a position in KERX in Q1 2017 and held it in 7 quarters. The position peaked at $150K in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • USCA RIA reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • USCA RIA sold 10,700 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $36K.
  • USCA RIA first reported a position in Keryx Biopharmaceuticals Inc in Q1 2017 and held it in 7 quarters.
  • USCA RIA's Keryx Biopharmaceuticals Inc position peaked at $150K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on USCA RIA's 13F filing for Q4 2018, filed 12 Feb 2019.